nodes	percent_of_prediction	percent_of_DWPC	metapath
Ivacaftor—CFTR—Glyburide—type 2 diabetes mellitus	0.203	0.364	CbGbCtD
Ivacaftor—CYP3A4—type 2 diabetes mellitus	0.148	0.534	CbGaD
Ivacaftor—ALB—type 2 diabetes mellitus	0.129	0.466	CbGaD
Ivacaftor—ORM1—Nateglinide—type 2 diabetes mellitus	0.0467	0.0837	CbGbCtD
Ivacaftor—ALB—Gliclazide—type 2 diabetes mellitus	0.0305	0.0547	CbGbCtD
Ivacaftor—ALB—Repaglinide—type 2 diabetes mellitus	0.0287	0.0514	CbGbCtD
Ivacaftor—ALB—Rosiglitazone—type 2 diabetes mellitus	0.024	0.0429	CbGbCtD
Ivacaftor—ALB—Valsartan—type 2 diabetes mellitus	0.0212	0.0379	CbGbCtD
Ivacaftor—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0211	0.0377	CbGbCtD
Ivacaftor—ALB—Nateglinide—type 2 diabetes mellitus	0.0197	0.0352	CbGbCtD
Ivacaftor—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0188	0.0336	CbGbCtD
Ivacaftor—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0136	0.0243	CbGbCtD
Ivacaftor—ALB—Glyburide—type 2 diabetes mellitus	0.0133	0.0238	CbGbCtD
Ivacaftor—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0126	0.0226	CbGbCtD
Ivacaftor—ALB—Losartan—type 2 diabetes mellitus	0.0122	0.0218	CbGbCtD
Ivacaftor—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0113	0.0202	CbGbCtD
Ivacaftor—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0103	0.0184	CbGbCtD
Ivacaftor—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00933	0.0167	CbGbCtD
Ivacaftor—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00899	0.0161	CbGbCtD
Ivacaftor—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00813	0.0146	CbGbCtD
Ivacaftor—ABCB1—Glyburide—type 2 diabetes mellitus	0.00695	0.0124	CbGbCtD
Ivacaftor—ABCB1—Losartan—type 2 diabetes mellitus	0.00636	0.0114	CbGbCtD
Ivacaftor—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00616	0.011	CbGbCtD
Ivacaftor—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00591	0.0106	CbGbCtD
Ivacaftor—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00591	0.0106	CbGbCtD
Ivacaftor—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00559	0.01	CbGbCtD
Ivacaftor—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00416	0.00746	CbGbCtD
Ivacaftor—CYP3A4—Losartan—type 2 diabetes mellitus	0.00381	0.00682	CbGbCtD
Ivacaftor—Upper respiratory tract infection—Valsartan—type 2 diabetes mellitus	0.000331	0.00284	CcSEcCtD
Ivacaftor—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.000329	0.00282	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Orlistat—type 2 diabetes mellitus	0.000328	0.0028	CcSEcCtD
Ivacaftor—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.000326	0.00279	CcSEcCtD
Ivacaftor—Breast disorder—Irbesartan—type 2 diabetes mellitus	0.00032	0.00274	CcSEcCtD
Ivacaftor—Arthralgia—Pioglitazone—type 2 diabetes mellitus	0.000319	0.00273	CcSEcCtD
Ivacaftor—Myalgia—Pioglitazone—type 2 diabetes mellitus	0.000319	0.00273	CcSEcCtD
Ivacaftor—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000318	0.00272	CcSEcCtD
Ivacaftor—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000318	0.00272	CcSEcCtD
Ivacaftor—Infestation NOS—Valsartan—type 2 diabetes mellitus	0.000318	0.00272	CcSEcCtD
Ivacaftor—Infestation—Valsartan—type 2 diabetes mellitus	0.000318	0.00272	CcSEcCtD
Ivacaftor—Nasopharyngitis—Irbesartan—type 2 diabetes mellitus	0.000317	0.00271	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Pioglitazone—type 2 diabetes mellitus	0.000317	0.00271	CcSEcCtD
Ivacaftor—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.000317	0.00271	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Repaglinide—type 2 diabetes mellitus	0.000316	0.0027	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.000315	0.00269	CcSEcCtD
Ivacaftor—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000314	0.00269	CcSEcCtD
Ivacaftor—Infestation—Orlistat—type 2 diabetes mellitus	0.000314	0.00269	CcSEcCtD
Ivacaftor—Infestation NOS—Orlistat—type 2 diabetes mellitus	0.000314	0.00269	CcSEcCtD
Ivacaftor—Nasal congestion—Ramipril—type 2 diabetes mellitus	0.000314	0.00269	CcSEcCtD
Ivacaftor—Rhinitis—Gliclazide—type 2 diabetes mellitus	0.000312	0.00266	CcSEcCtD
Ivacaftor—Arthralgia—Sitagliptin—type 2 diabetes mellitus	0.00031	0.00265	CcSEcCtD
Ivacaftor—Myalgia—Sitagliptin—type 2 diabetes mellitus	0.00031	0.00265	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.000308	0.00263	CcSEcCtD
Ivacaftor—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.000305	0.00261	CcSEcCtD
Ivacaftor—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000305	0.00261	CcSEcCtD
Ivacaftor—Infection—Pioglitazone—type 2 diabetes mellitus	0.000304	0.0026	CcSEcCtD
Ivacaftor—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000304	0.0026	CcSEcCtD
Ivacaftor—Rash—Tolazamide—type 2 diabetes mellitus	0.000304	0.0026	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Metformin—type 2 diabetes mellitus	0.000302	0.00258	CcSEcCtD
Ivacaftor—Headache—Tolazamide—type 2 diabetes mellitus	0.000302	0.00258	CcSEcCtD
Ivacaftor—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000302	0.00258	CcSEcCtD
Ivacaftor—Breast disorder—Losartan—type 2 diabetes mellitus	0.000302	0.00258	CcSEcCtD
Ivacaftor—Rash—Linagliptin—type 2 diabetes mellitus	0.0003	0.00257	CcSEcCtD
Ivacaftor—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.0003	0.00257	CcSEcCtD
Ivacaftor—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.0003	0.00257	CcSEcCtD
Ivacaftor—Headache—Linagliptin—type 2 diabetes mellitus	0.000299	0.00255	CcSEcCtD
Ivacaftor—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.000297	0.00254	CcSEcCtD
Ivacaftor—Infection—Sitagliptin—type 2 diabetes mellitus	0.000295	0.00253	CcSEcCtD
Ivacaftor—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000295	0.00252	CcSEcCtD
Ivacaftor—Hypoglycaemia—Ramipril—type 2 diabetes mellitus	0.000293	0.00251	CcSEcCtD
Ivacaftor—Rash—Acarbose—type 2 diabetes mellitus	0.000292	0.0025	CcSEcCtD
Ivacaftor—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.000291	0.00249	CcSEcCtD
Ivacaftor—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000291	0.00249	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Glipizide—type 2 diabetes mellitus	0.000291	0.00249	CcSEcCtD
Ivacaftor—Tinnitus—Gliclazide—type 2 diabetes mellitus	0.00029	0.00248	CcSEcCtD
Ivacaftor—Infestation NOS—Metformin—type 2 diabetes mellitus	0.00029	0.00248	CcSEcCtD
Ivacaftor—Infestation—Metformin—type 2 diabetes mellitus	0.00029	0.00248	CcSEcCtD
Ivacaftor—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.000289	0.00247	CcSEcCtD
Ivacaftor—Rhinitis—Valsartan—type 2 diabetes mellitus	0.000286	0.00245	CcSEcCtD
Ivacaftor—Nausea—Tolazamide—type 2 diabetes mellitus	0.000286	0.00245	CcSEcCtD
Ivacaftor—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000286	0.00245	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Irbesartan—type 2 diabetes mellitus	0.000285	0.00244	CcSEcCtD
Ivacaftor—Rash—Nateglinide—type 2 diabetes mellitus	0.000281	0.00241	CcSEcCtD
Ivacaftor—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000281	0.0024	CcSEcCtD
Ivacaftor—Connective tissue disorder—Valsartan—type 2 diabetes mellitus	0.000281	0.0024	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Pioglitazone—type 2 diabetes mellitus	0.000279	0.00239	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.000279	0.00238	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000276	0.00236	CcSEcCtD
Ivacaftor—Nausea—Acarbose—type 2 diabetes mellitus	0.000275	0.00235	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.000271	0.00232	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Losartan—type 2 diabetes mellitus	0.000268	0.00229	CcSEcCtD
Ivacaftor—Infection—Bromocriptine—type 2 diabetes mellitus	0.000267	0.00229	CcSEcCtD
Ivacaftor—Nausea—Nateglinide—type 2 diabetes mellitus	0.000265	0.00227	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000264	0.00226	CcSEcCtD
Ivacaftor—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000264	0.00226	CcSEcCtD
Ivacaftor—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000264	0.00226	CcSEcCtD
Ivacaftor—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000261	0.00223	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000261	0.00223	CcSEcCtD
Ivacaftor—Rhinitis—Metformin—type 2 diabetes mellitus	0.000261	0.00223	CcSEcCtD
Ivacaftor—Breast disorder—Ramipril—type 2 diabetes mellitus	0.000259	0.00221	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000257	0.0022	CcSEcCtD
Ivacaftor—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000257	0.0022	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000257	0.00219	CcSEcCtD
Ivacaftor—Arthralgia—Glyburide—type 2 diabetes mellitus	0.000256	0.00219	CcSEcCtD
Ivacaftor—Myalgia—Glyburide—type 2 diabetes mellitus	0.000256	0.00219	CcSEcCtD
Ivacaftor—Connective tissue disorder—Metformin—type 2 diabetes mellitus	0.000255	0.00219	CcSEcCtD
Ivacaftor—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.000254	0.00217	CcSEcCtD
Ivacaftor—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000253	0.00216	CcSEcCtD
Ivacaftor—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00025	0.00214	CcSEcCtD
Ivacaftor—Rhinitis—Irbesartan—type 2 diabetes mellitus	0.000246	0.0021	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000244	0.00209	CcSEcCtD
Ivacaftor—Rash—Repaglinide—type 2 diabetes mellitus	0.000243	0.00208	CcSEcCtD
Ivacaftor—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000243	0.00208	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000243	0.00208	CcSEcCtD
Ivacaftor—Headache—Repaglinide—type 2 diabetes mellitus	0.000242	0.00207	CcSEcCtD
Ivacaftor—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000241	0.00206	CcSEcCtD
Ivacaftor—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000241	0.00206	CcSEcCtD
Ivacaftor—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.000241	0.00206	CcSEcCtD
Ivacaftor—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000236	0.00202	CcSEcCtD
Ivacaftor—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000235	0.00201	CcSEcCtD
Ivacaftor—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000234	0.002	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000232	0.00199	CcSEcCtD
Ivacaftor—Rhinitis—Losartan—type 2 diabetes mellitus	0.000231	0.00198	CcSEcCtD
Ivacaftor—Myalgia—Gliclazide—type 2 diabetes mellitus	0.00023	0.00197	CcSEcCtD
Ivacaftor—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.00023	0.00197	CcSEcCtD
Ivacaftor—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00023	0.00197	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.00023	0.00197	CcSEcCtD
Ivacaftor—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00023	0.00197	CcSEcCtD
Ivacaftor—Nausea—Repaglinide—type 2 diabetes mellitus	0.000229	0.00196	CcSEcCtD
Ivacaftor—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000229	0.00196	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000229	0.00196	CcSEcCtD
Ivacaftor—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000229	0.00196	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000224	0.00192	CcSEcCtD
Ivacaftor—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000221	0.00189	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00022	0.00188	CcSEcCtD
Ivacaftor—Infection—Gliclazide—type 2 diabetes mellitus	0.000219	0.00188	CcSEcCtD
Ivacaftor—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000219	0.00187	CcSEcCtD
Ivacaftor—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000217	0.00185	CcSEcCtD
Ivacaftor—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000216	0.00185	CcSEcCtD
Ivacaftor—Tinnitus—Losartan—type 2 diabetes mellitus	0.000215	0.00184	CcSEcCtD
Ivacaftor—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000214	0.00183	CcSEcCtD
Ivacaftor—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000213	0.00182	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000212	0.00182	CcSEcCtD
Ivacaftor—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000212	0.00181	CcSEcCtD
Ivacaftor—Myalgia—Valsartan—type 2 diabetes mellitus	0.000212	0.00181	CcSEcCtD
Ivacaftor—Dizziness—Glipizide—type 2 diabetes mellitus	0.000211	0.00181	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00021	0.0018	CcSEcCtD
Ivacaftor—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000209	0.00179	CcSEcCtD
Ivacaftor—Myalgia—Orlistat—type 2 diabetes mellitus	0.000209	0.00179	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000208	0.00178	CcSEcCtD
Ivacaftor—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000204	0.00174	CcSEcCtD
Ivacaftor—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000203	0.00174	CcSEcCtD
Ivacaftor—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000202	0.00173	CcSEcCtD
Ivacaftor—Infection—Valsartan—type 2 diabetes mellitus	0.000201	0.00172	CcSEcCtD
Ivacaftor—Rash—Glipizide—type 2 diabetes mellitus	0.000201	0.00172	CcSEcCtD
Ivacaftor—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000201	0.00172	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000201	0.00172	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000201	0.00172	CcSEcCtD
Ivacaftor—Headache—Glipizide—type 2 diabetes mellitus	0.0002	0.00171	CcSEcCtD
Ivacaftor—Infection—Orlistat—type 2 diabetes mellitus	0.000199	0.0017	CcSEcCtD
Ivacaftor—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000199	0.0017	CcSEcCtD
Ivacaftor—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000197	0.00169	CcSEcCtD
Ivacaftor—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000197	0.00169	CcSEcCtD
Ivacaftor—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000197	0.00168	CcSEcCtD
Ivacaftor—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000197	0.00168	CcSEcCtD
Ivacaftor—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000195	0.00167	CcSEcCtD
Ivacaftor—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000195	0.00166	CcSEcCtD
Ivacaftor—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000194	0.00166	CcSEcCtD
Ivacaftor—Myalgia—Metformin—type 2 diabetes mellitus	0.000193	0.00165	CcSEcCtD
Ivacaftor—Headache—Pioglitazone—type 2 diabetes mellitus	0.000192	0.00164	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000191	0.00164	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000191	0.00163	CcSEcCtD
Ivacaftor—Nausea—Glipizide—type 2 diabetes mellitus	0.00019	0.00162	CcSEcCtD
Ivacaftor—Rash—Glimepiride—type 2 diabetes mellitus	0.000188	0.00161	CcSEcCtD
Ivacaftor—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000188	0.00161	CcSEcCtD
Ivacaftor—Rash—Sitagliptin—type 2 diabetes mellitus	0.000187	0.0016	CcSEcCtD
Ivacaftor—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000187	0.0016	CcSEcCtD
Ivacaftor—Headache—Glimepiride—type 2 diabetes mellitus	0.000187	0.0016	CcSEcCtD
Ivacaftor—Headache—Sitagliptin—type 2 diabetes mellitus	0.000186	0.00159	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000185	0.00158	CcSEcCtD
Ivacaftor—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000185	0.00158	CcSEcCtD
Ivacaftor—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000184	0.00157	CcSEcCtD
Ivacaftor—Infection—Metformin—type 2 diabetes mellitus	0.000183	0.00157	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000183	0.00156	CcSEcCtD
Ivacaftor—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000182	0.00156	CcSEcCtD
Ivacaftor—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000182	0.00156	CcSEcCtD
Ivacaftor—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000181	0.00155	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000181	0.00154	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000181	0.00154	CcSEcCtD
Ivacaftor—Skin disorder—Metformin—type 2 diabetes mellitus	0.000179	0.00153	CcSEcCtD
Ivacaftor—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000178	0.00153	CcSEcCtD
Ivacaftor—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000178	0.00152	CcSEcCtD
Ivacaftor—Nausea—Glimepiride—type 2 diabetes mellitus	0.000177	0.00151	CcSEcCtD
Ivacaftor—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000177	0.00151	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000175	0.0015	CcSEcCtD
Ivacaftor—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000175	0.00149	CcSEcCtD
Ivacaftor—Infection—Irbesartan—type 2 diabetes mellitus	0.000173	0.00148	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000173	0.00148	CcSEcCtD
Ivacaftor—Arthralgia—Losartan—type 2 diabetes mellitus	0.000171	0.00146	CcSEcCtD
Ivacaftor—Myalgia—Losartan—type 2 diabetes mellitus	0.000171	0.00146	CcSEcCtD
Ivacaftor—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000171	0.00146	CcSEcCtD
Ivacaftor—Rash—Bromocriptine—type 2 diabetes mellitus	0.00017	0.00145	CcSEcCtD
Ivacaftor—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000169	0.00145	CcSEcCtD
Ivacaftor—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000169	0.00145	CcSEcCtD
Ivacaftor—Headache—Bromocriptine—type 2 diabetes mellitus	0.000168	0.00144	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000168	0.00144	CcSEcCtD
Ivacaftor—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000168	0.00144	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000166	0.00142	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000164	0.0014	CcSEcCtD
Ivacaftor—Infection—Losartan—type 2 diabetes mellitus	0.000163	0.00139	CcSEcCtD
Ivacaftor—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000161	0.00138	CcSEcCtD
Ivacaftor—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00016	0.00137	CcSEcCtD
Ivacaftor—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00016	0.00137	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000159	0.00136	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000159	0.00136	CcSEcCtD
Ivacaftor—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000158	0.00136	CcSEcCtD
Ivacaftor—Rash—Glyburide—type 2 diabetes mellitus	0.000155	0.00133	CcSEcCtD
Ivacaftor—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000155	0.00132	CcSEcCtD
Ivacaftor—Headache—Glyburide—type 2 diabetes mellitus	0.000154	0.00132	CcSEcCtD
Ivacaftor—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000151	0.00129	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000151	0.00129	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00015	0.00129	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000149	0.00128	CcSEcCtD
Ivacaftor—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000147	0.00126	CcSEcCtD
Ivacaftor—Myalgia—Ramipril—type 2 diabetes mellitus	0.000147	0.00126	CcSEcCtD
Ivacaftor—Nausea—Glyburide—type 2 diabetes mellitus	0.000146	0.00125	CcSEcCtD
Ivacaftor—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000146	0.00125	CcSEcCtD
Ivacaftor—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000146	0.00125	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000146	0.00125	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000143	0.00122	CcSEcCtD
Ivacaftor—Rash—Gliclazide—type 2 diabetes mellitus	0.000139	0.00119	CcSEcCtD
Ivacaftor—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000139	0.00119	CcSEcCtD
Ivacaftor—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000139	0.00119	CcSEcCtD
Ivacaftor—Headache—Gliclazide—type 2 diabetes mellitus	0.000138	0.00118	CcSEcCtD
Ivacaftor—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000138	0.00118	CcSEcCtD
Ivacaftor—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000138	0.00118	CcSEcCtD
Ivacaftor—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000137	0.00117	CcSEcCtD
Ivacaftor—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000137	0.00117	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000134	0.00115	CcSEcCtD
Ivacaftor—Dizziness—Valsartan—type 2 diabetes mellitus	0.000134	0.00115	CcSEcCtD
Ivacaftor—Dizziness—Orlistat—type 2 diabetes mellitus	0.000133	0.00113	CcSEcCtD
Ivacaftor—Nausea—Gliclazide—type 2 diabetes mellitus	0.000131	0.00112	CcSEcCtD
Ivacaftor—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00013	0.00111	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000128	0.0011	CcSEcCtD
Ivacaftor—Rash—Valsartan—type 2 diabetes mellitus	0.000128	0.00109	CcSEcCtD
Ivacaftor—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000128	0.00109	CcSEcCtD
Ivacaftor—Headache—Valsartan—type 2 diabetes mellitus	0.000127	0.00109	CcSEcCtD
Ivacaftor—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000126	0.00108	CcSEcCtD
Ivacaftor—Rash—Orlistat—type 2 diabetes mellitus	0.000126	0.00108	CcSEcCtD
Ivacaftor—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000126	0.00108	CcSEcCtD
Ivacaftor—Headache—Orlistat—type 2 diabetes mellitus	0.000126	0.00107	CcSEcCtD
Ivacaftor—Dizziness—Metformin—type 2 diabetes mellitus	0.000122	0.00104	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000121	0.00104	CcSEcCtD
Ivacaftor—Nausea—Valsartan—type 2 diabetes mellitus	0.00012	0.00103	CcSEcCtD
Ivacaftor—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000119	0.00102	CcSEcCtD
Ivacaftor—Nausea—Orlistat—type 2 diabetes mellitus	0.000119	0.00102	CcSEcCtD
Ivacaftor—Rash—Metformin—type 2 diabetes mellitus	0.000116	0.000996	CcSEcCtD
Ivacaftor—Dermatitis—Metformin—type 2 diabetes mellitus	0.000116	0.000995	CcSEcCtD
Ivacaftor—Headache—Metformin—type 2 diabetes mellitus	0.000116	0.00099	CcSEcCtD
Ivacaftor—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000115	0.000986	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000115	0.000984	CcSEcCtD
Ivacaftor—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000112	0.00096	CcSEcCtD
Ivacaftor—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000111	0.000951	CcSEcCtD
Ivacaftor—Rash—Irbesartan—type 2 diabetes mellitus	0.00011	0.00094	CcSEcCtD
Ivacaftor—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00011	0.000939	CcSEcCtD
Ivacaftor—Nausea—Metformin—type 2 diabetes mellitus	0.00011	0.000938	CcSEcCtD
Ivacaftor—Headache—Irbesartan—type 2 diabetes mellitus	0.000109	0.000934	CcSEcCtD
Ivacaftor—Dizziness—Losartan—type 2 diabetes mellitus	0.000108	0.000928	CcSEcCtD
Ivacaftor—Nausea—Irbesartan—type 2 diabetes mellitus	0.000104	0.000886	CcSEcCtD
Ivacaftor—Rash—Losartan—type 2 diabetes mellitus	0.000103	0.000885	CcSEcCtD
Ivacaftor—Dermatitis—Losartan—type 2 diabetes mellitus	0.000103	0.000884	CcSEcCtD
Ivacaftor—Headache—Losartan—type 2 diabetes mellitus	0.000103	0.000879	CcSEcCtD
Ivacaftor—Nausea—Losartan—type 2 diabetes mellitus	9.74e-05	0.000833	CcSEcCtD
Ivacaftor—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.62e-05	0.000823	CcSEcCtD
Ivacaftor—Dizziness—Ramipril—type 2 diabetes mellitus	9.3e-05	0.000796	CcSEcCtD
Ivacaftor—Rash—Ramipril—type 2 diabetes mellitus	8.87e-05	0.000759	CcSEcCtD
Ivacaftor—Dermatitis—Ramipril—type 2 diabetes mellitus	8.86e-05	0.000758	CcSEcCtD
Ivacaftor—Headache—Ramipril—type 2 diabetes mellitus	8.81e-05	0.000754	CcSEcCtD
Ivacaftor—Nausea—Ramipril—type 2 diabetes mellitus	8.35e-05	0.000715	CcSEcCtD
Ivacaftor—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	1.28e-05	0.000264	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.28e-05	0.000264	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.26e-05	0.000261	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	1.26e-05	0.00026	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.26e-05	0.00026	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—CD36—type 2 diabetes mellitus	1.26e-05	0.00026	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.25e-05	0.000259	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	1.24e-05	0.000257	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.24e-05	0.000256	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	1.23e-05	0.000253	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	1.23e-05	0.000253	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PCK1—type 2 diabetes mellitus	1.22e-05	0.000253	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.21e-05	0.000249	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.2e-05	0.000248	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	1.19e-05	0.000246	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	1.18e-05	0.000244	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	1.18e-05	0.000244	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.18e-05	0.000243	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	1.18e-05	0.000243	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	1.16e-05	0.00024	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	1.16e-05	0.00024	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.15e-05	0.000238	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.15e-05	0.000238	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	1.15e-05	0.000237	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—HK1—type 2 diabetes mellitus	1.15e-05	0.000237	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.15e-05	0.000237	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	1.14e-05	0.000236	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	1.14e-05	0.000236	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	1.14e-05	0.000236	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	1.14e-05	0.000236	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.12e-05	0.000232	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	1.11e-05	0.00023	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	1.11e-05	0.000229	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GCKR—type 2 diabetes mellitus	1.11e-05	0.000229	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—LPA—type 2 diabetes mellitus	1.11e-05	0.000229	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	1.11e-05	0.000229	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.1e-05	0.000228	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.1e-05	0.000227	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	1.1e-05	0.000227	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.09e-05	0.000225	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.09e-05	0.000225	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.09e-05	0.000225	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	1.07e-05	0.000222	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	1.07e-05	0.00022	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.07e-05	0.00022	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	1.06e-05	0.000219	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.05e-05	0.000217	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.05e-05	0.000217	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	1.05e-05	0.000216	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.04e-05	0.000215	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	1.03e-05	0.000214	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.03e-05	0.000213	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.03e-05	0.000213	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.01e-05	0.000209	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.01e-05	0.000209	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	1e-05	0.000207	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	9.99e-06	0.000206	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	9.87e-06	0.000204	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	9.83e-06	0.000203	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	9.81e-06	0.000203	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	9.71e-06	0.0002	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	9.71e-06	0.0002	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	9.71e-06	0.0002	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	9.71e-06	0.0002	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	9.61e-06	0.000198	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	9.61e-06	0.000198	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	9.5e-06	0.000196	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	9.3e-06	0.000192	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	9.28e-06	0.000192	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	9.28e-06	0.000192	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	9.28e-06	0.000192	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	9.28e-06	0.000192	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	9.28e-06	0.000192	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	9.22e-06	0.00019	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	9.17e-06	0.000189	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	9.17e-06	0.000189	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	9.03e-06	0.000186	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—MTR—type 2 diabetes mellitus	9.03e-06	0.000186	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	8.99e-06	0.000186	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	8.87e-06	0.000183	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	8.86e-06	0.000183	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	8.8e-06	0.000182	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—HBA1—type 2 diabetes mellitus	8.8e-06	0.000182	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GCK—type 2 diabetes mellitus	8.8e-06	0.000182	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—LIPC—type 2 diabetes mellitus	8.8e-06	0.000182	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	8.75e-06	0.000181	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	8.71e-06	0.00018	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	8.65e-06	0.000179	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	8.59e-06	0.000177	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CETP—type 2 diabetes mellitus	8.49e-06	0.000175	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	8.49e-06	0.000175	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	8.49e-06	0.000175	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.32e-06	0.000172	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	8.32e-06	0.000172	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	8.32e-06	0.000172	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	8.27e-06	0.000171	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	8.08e-06	0.000167	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	7.91e-06	0.000163	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	7.91e-06	0.000163	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	7.89e-06	0.000163	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	7.89e-06	0.000163	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	7.89e-06	0.000163	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	7.89e-06	0.000163	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	7.89e-06	0.000163	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	7.89e-06	0.000163	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	7.76e-06	0.00016	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CTGF—type 2 diabetes mellitus	7.75e-06	0.00016	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	7.71e-06	0.000159	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	7.71e-06	0.000159	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	7.71e-06	0.000159	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	7.68e-06	0.000159	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	7.66e-06	0.000158	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.57e-06	0.000156	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	7.56e-06	0.000156	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.56e-06	0.000156	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	7.53e-06	0.000155	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	7.51e-06	0.000155	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	7.44e-06	0.000154	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	7.42e-06	0.000153	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	7.3e-06	0.000151	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	7.28e-06	0.00015	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	7.28e-06	0.00015	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	7.22e-06	0.000149	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	7.15e-06	0.000148	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	7.14e-06	0.000147	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	7.14e-06	0.000147	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	7.03e-06	0.000145	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	7.03e-06	0.000145	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	7.03e-06	0.000145	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	6.96e-06	0.000144	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.93e-06	0.000143	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	6.92e-06	0.000143	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	6.92e-06	0.000143	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	6.92e-06	0.000143	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GCG—type 2 diabetes mellitus	6.84e-06	0.000141	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	6.84e-06	0.000141	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	6.79e-06	0.00014	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	6.73e-06	0.000139	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.61e-06	0.000137	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.59e-06	0.000136	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	6.58e-06	0.000136	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	6.32e-06	0.000131	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	6.25e-06	0.000129	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	6.25e-06	0.000129	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	6.19e-06	0.000128	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—SRC—type 2 diabetes mellitus	6.15e-06	0.000127	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	6.1e-06	0.000126	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	6e-06	0.000124	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	6e-06	0.000124	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	5.99e-06	0.000124	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.98e-06	0.000123	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.98e-06	0.000123	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.98e-06	0.000123	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.98e-06	0.000123	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GNB3—type 2 diabetes mellitus	5.9e-06	0.000122	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.9e-06	0.000122	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	5.87e-06	0.000121	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CAT—type 2 diabetes mellitus	5.79e-06	0.00012	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.73e-06	0.000118	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—APOB—type 2 diabetes mellitus	5.62e-06	0.000116	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	5.5e-06	0.000114	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	5.47e-06	0.000113	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—LPL—type 2 diabetes mellitus	5.37e-06	0.000111	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.33e-06	0.00011	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	5.26e-06	0.000109	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GPX1—type 2 diabetes mellitus	5.24e-06	0.000108	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	5.17e-06	0.000107	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.17e-06	0.000107	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	5.14e-06	0.000106	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CD36—type 2 diabetes mellitus	5.1e-06	0.000105	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	5.08e-06	0.000105	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	5.04e-06	0.000104	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.98e-06	0.000103	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	4.93e-06	0.000102	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.87e-06	0.000101	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.87e-06	0.000101	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	4.83e-06	9.98e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	4.79e-06	9.9e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.78e-06	9.87e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.75e-06	9.81e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.75e-06	9.81e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.75e-06	9.81e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PPARA—type 2 diabetes mellitus	4.74e-06	9.79e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.72e-06	9.75e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	4.7e-06	9.71e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.64e-06	9.57e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	4.61e-06	9.51e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—AGT—type 2 diabetes mellitus	4.59e-06	9.48e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	4.59e-06	9.48e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.58e-06	9.46e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CALM1—type 2 diabetes mellitus	4.52e-06	9.33e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—APOE—type 2 diabetes mellitus	4.5e-06	9.29e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	4.47e-06	9.23e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—APOA1—type 2 diabetes mellitus	4.45e-06	9.19e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.41e-06	9.11e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.26e-06	8.8e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.26e-06	8.8e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.26e-06	8.8e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	4.24e-06	8.75e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.18e-06	8.63e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	4.16e-06	8.58e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.14e-06	8.56e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.06e-06	8.37e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	4.03e-06	8.31e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.96e-06	8.17e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.94e-06	8.14e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PPARG—type 2 diabetes mellitus	3.92e-06	8.09e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.9e-06	8.05e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.9e-06	8.05e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.85e-06	7.95e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.85e-06	7.95e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—INS—type 2 diabetes mellitus	3.85e-06	7.94e-05	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	3.82e-06	7.89e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.69e-06	7.63e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.69e-06	7.63e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	3.44e-06	7.09e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	3.37e-06	6.96e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—NOS3—type 2 diabetes mellitus	3.37e-06	6.96e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—INS—type 2 diabetes mellitus	3.37e-06	6.96e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.18e-06	6.57e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.18e-06	6.57e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.17e-06	6.54e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.13e-06	6.46e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	3.09e-06	6.38e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	3.08e-06	6.37e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.04e-06	6.27e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.95e-06	6.1e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.95e-06	6.1e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.95e-06	6.1e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.9e-06	5.98e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.84e-06	5.86e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.83e-06	5.84e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.75e-06	5.69e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.72e-06	5.62e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.7e-06	5.58e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.61e-06	5.39e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.56e-06	5.29e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.48e-06	5.12e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.44e-06	5.03e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.43e-06	5.02e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.4e-06	4.96e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.12e-06	4.37e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.08e-06	4.29e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.9e-06	3.93e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.82e-06	3.76e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.82e-06	3.76e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.66e-06	3.44e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.55e-06	3.2e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.36e-06	2.8e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	8.37e-07	1.73e-05	CbGpPWpGaD
